1. Due to the emergence of COVID-19, Careplus Group Berhad (“Careplus” or “Company”) appreciate that its shareholders may be wary of attending the Extraordinary General Meeting (“EGM”) to be held on 6 May 2020. Hence, Careplus is organising this Q&A Session ahead of the EGM to provide its shareholders a forum to raise any questions relating to the Proposed Joint Venture to the directors of Careplus.
2. The Q&A Session is limited to the following:
(i) only the shareholders of Careplus may attend; and
(ii) the session is limited to only 100 pax.
Registration of attendees for the Q&A Session are therefore on a first come first served basis.
3. In line with Careplus’ commitment to the Government of Malaysia’s continued efforts to prevent the spread of COVID-19, the Company strongly encourage its shareholders to utilise the Q&A Session. Shareholders of Careplus are also encouraged to appoint the Chairman of the EGM (or any other person) to act as proxy to attend and vote at the EGM on their behalf by submitting their physical proxy form with predetermined voting instruction to the Company at the stated address.
4. Please submit any questions after you have been registered. Closing Date: 22/04/2020 (WED), 5:00 PM